![IJMS | Free Full-Text | Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer IJMS | Free Full-Text | Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer](https://pub.mdpi-res.com/ijms/ijms-22-05632/article_deploy/html/images/ijms-22-05632-g001.png?1622003640)
IJMS | Free Full-Text | Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer
![Frontiers | Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System Frontiers | Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System](https://www.frontiersin.org/files/Articles/833114/fmed-08-833114-HTML/image_m/fmed-08-833114-g001.jpg)
Frontiers | Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System
![Current insights into the expression and functions of tumor-derived immunoglobulins | Cell Death Discovery Current insights into the expression and functions of tumor-derived immunoglobulins | Cell Death Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41420-021-00550-9/MediaObjects/41420_2021_550_Fig1_HTML.png)
Current insights into the expression and functions of tumor-derived immunoglobulins | Cell Death Discovery
![Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals](https://images.novusbio.com/fullsize2/Melanoma-Marker-(MART-1-+-Tyrosinase-+-gp100)-Antibody-(A103-+-T311-+-HMB45)-Flow-(Intracellular)-NBP2-34339-img0003.jpg)